CSat Investment Advisory’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$50K Buy
831
+154
+23% +$8.5K 0.04% 194
2020
Q4
$36K Sell
677
-719
-52% -$37.3K 0.03% 224
2020
Q3
$66K Buy
1,396
+204
+17% +$10.5K 0.01% 618
2020
Q2
$62K Buy
1,192
+312
+35% +$16.1K 0.01% 639
2020
Q1
$42K Buy
880
+74
+9% +$3.84K 0.01% 564
2019
Q4
$41K Sell
806
-27
-3% -$1.4K 0.01% 649
2019
Q3
$39K Sell
833
-10
-1% -$456 0.01% 617
2019
Q2
$39K Buy
843
+418
+98% +$19.3K 0.01% 616
2019
Q1
$20K Buy
425
+86
+25% +$4.31K 0.01% 315
2018
Q4
$15K Buy
339
+98
+41% +$5.11K 0.01% 343
2018
Q3
$13K Buy
241
+46
+24% +$2.35K 0.01% 311
2018
Q2
$10K Buy
+195
New +$11.1K 0.01% 340

Other funds holding CAH

CSat Investment Advisory's CAH Position: Q1 2021 in Review

CSat Investment Advisory increased its Cardinal Health (CAH) stake by 23% in Q1 2021, buying an estimated $8.5K and bringing the position to 831 shares worth $50K. The position accounts for 0.04% of the portfolio, ranked #194.

CSat Investment Advisory first reported a position in CAH in Q2 2018 and has held it in 12 quarters since. The position peaked at $66K in Q3 2020. 802 funds tracked by Wall St. Rank hold CAH as of Q1 2021.

  • CSat Investment Advisory held 831 shares of Cardinal Health worth $50K as of Q1 2021.
  • CSat Investment Advisory bought 154 Cardinal Health shares in Q1 2021, an estimated $8.5K.
  • Cardinal Health made up 0.04% of CSat Investment Advisory's portfolio in Q1 2021, its #194 holding.
  • CSat Investment Advisory first reported a position in Cardinal Health in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Cardinal Health position peaked at $66K in Q3 2020.
  • 802 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.